Welcome to our dedicated page for Esquire Finl Hldgs SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Esquire Financial Holdings, Inc. filings document the public-company record for a Maryland financial holding company whose common stock trades on Nasdaq under ESQ and whose bank subsidiary is Esquire Bank, National Association.
The filing record includes Form 8-K disclosures for earnings releases, Regulation FD presentations, regular dividend actions, material agreements, and director or committee changes. Proxy materials cover annual-meeting governance, director matters, executive compensation, equity awards, pay-versus-performance data, and shareholder voting matters. The disclosures also identify the company's capital structure, banking subsidiary, Nasdaq-listed common stock, and governance framework.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. issued a joint press release on June 9, 2026 announcing receipt of all regulatory approvals related to the merger of Signature with and into Esquire. The filing states a registration statement on Form S-4 has been filed and a joint proxy statement/prospectus was mailed on May 11, 2026 seeking required shareholder approvals. The press release is filed as Exhibit 99.1 and is incorporated by reference. The report includes customary forward-looking statements and directs readers to the Form S-4 and joint proxy statement/prospectus for detailed terms and risks.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. have received all required regulatory approvals and waivers for their proposed merger. Approvals include a waiver of prior approval for the holding company merger from the Federal Reserve Bank of New York and approval of the bank merger from the Office of the Comptroller of the Currency.
The transaction is not yet complete. Closing of the merger remains subject to approvals from Esquire stockholders and Signature shareholders, along with certain other customary closing conditions. Both companies reiterate typical forward-looking statement cautions and direct investors to the Form S-4 registration statement and joint proxy statement/prospectus for detailed information about the proposed deal.
Esquire Financial Holdings, Inc. reported the results of its Annual Meeting of Stockholders held on May 28, 2026, where all proposals were approved. Of 8,637,034 shares outstanding and entitled to vote, 7,625,348 shares were represented in person or by proxy, indicating a strong quorum.
Stockholders elected Raymond Kelly, Robert J. Mitzman and Kevin C. Waterhouse to three-year terms and Todd Deutsch to a two-year term, with each nominee receiving substantially more votes "for" than "withheld." Proposals 2 and 3 also passed by wide margins, with more than 6 million shares voting in favor of each.
Esquire Financial Holdings, Inc. reported net income of $12.2 million for the three months ended March 31, 2026, up from $11.4 million a year earlier. Diluted earnings per share were $1.40 versus $1.33, driven by higher net interest income of $34.0 million compared with $27.6 million in 2025.
Total assets reached $2.42 billion, with loans held for investment rising to $1.82 billion and deposits to $2.10 billion. Credit costs increased, with a $2.7 million provision for credit losses and net charge-offs tied mainly to a foreclosed multifamily loan. The company also incurred $1.3 million in merger expenses related to a planned stock-for-stock acquisition of Signature Bancorporation, where Signature shareholders are expected to receive 2.63 shares of Esquire common stock per Signature share, subject to an adjustable exchange ratio between 2.50 and 2.80.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. have agreed to combine in a triangular two-step merger under an Agreement and Plan of Merger dated March 11, 2026. Signature shareholders will receive 2.630 shares of Esquire common stock per Signature share, subject to adjustment between 2.500 and 2.800 based on proceeds from the disposition of four Schedule A loans (aggregate ~$70M). As of the statement date, two Schedule A loans (aggregate principal $30.3M) were sold for aggregate proceeds of $12.6M (≈42% recovery), producing a maximum obtainable exchange ratio of 2.715. Esquire estimates issuing approximately 3.76 million shares to former Signature shareholders, who would own about 30% of Esquire post-closing; existing Esquire holders would own about 70%. Special meetings of Signature and Esquire stockholders are scheduled for June 23, 2026 to vote on the merger and related proposals. The merger is expected to qualify as a tax-free reorganization for U.S. federal income tax purposes for Signature shareholders, subject to the legal opinions required by the agreement.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. have agreed to merge under an Agreement and Plan of Merger dated March 11, 2026. Signature shareholders will receive 2.630 shares of Esquire common stock per Signature share, subject to an adjustment mechanism tied to proceeds from the sale of four loans (the "Schedule A Loans") with a contractual exchange ratio range of 2.500 to 2.800.
As disclosed, two Schedule A Loans (aggregate principal $30.3M) were sold for aggregate proceeds of $12.6M (a 42% recovery). Esquire expects to issue approximately 3.76 million shares to Signature shareholders at the maximum obtainable ratio of 2.715, which would result in former Signature holders owning about 30% of Esquire post-merger. Special meetings for shareholder approvals are scheduled for June 23, 2026.
Esquire Financial Holdings, Inc. executive Martin S. Korn, EVP and CTO, reported his initial ownership of company equity. He holds 20,382 shares of common stock indirectly through a trust and 18,417 shares directly, including restricted stock that vests in equal annual installments beginning on various December dates from 2024 through 2028. He also holds several stock option awards on common stock, fully or time-vested, covering tranches of 2,000–6,500 underlying shares each, with exercise prices from $19.25 to $106.23 per share and expiration dates between 2028 and 2035.
Esquire Financial Holdings, Inc. declared a regular quarterly cash dividend of $0.20 per share on its common stock. The dividend will be paid on June 1, 2026 to stockholders who are on the company’s books as of the record date of May 15, 2026. This continues the company’s practice of returning cash to common stockholders through regular dividends.